Lamictal XR Monotherapy: Will Ex-U.S. Data Invalidate Historical Comparison?
FDA reviewers cite issues with the study design GSK used in its sNDA, but still find evidence of efficacy for partial seizures.
FDA reviewers cite issues with the study design GSK used in its sNDA, but still find evidence of efficacy for partial seizures.